Nisco James 4
4 · LISATA THERAPEUTICS, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
Nisco James
SVP, Fin/Treas, Chief Actg Off
Transactions
- Tax Payment
Common Stock
2024-10-01$2.93/sh−1,701$4,984→ 12,956 total - Award
Common Stock
2024-10-01$2.93/sh+3,300$9,669→ 14,657 total
Footnotes (3)
- [F1]Reflects 3,300 in performance-based stock units, the criteria for which was satisfied on October 1, 2024 and which vested in full on that same day.
- [F2]Includes 9,482 unvested restricted stock.
- [F3]Shares withheld as payment of a tax liability on vesting of performance-based stock units.